Stock Trading Alert: Indexes Continue To Fluctuate Along Record Levels – Which Direction Is Next?By: Paul Rejczak | Mon, May 4, 2015SharePrintEmailStock Trading Alert originally published on May 4, 2015, 6:36 AM:Briefly: In our opinion, speculative short positions are favored (with stop-loss at 2,140, and profit target at 1,980, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook […]
By Ben LevisohnIt’s been a bad, bad week for biotech stocks. The iShares Nasdaq Biotech Index ETF (IBB) had dropped 9.3% this week through Thursday’s close, while Amgen (AMGN), Biogen Idec (BIIB), and Celgene (CELG) also suffered big losses. Evercore ISI’s Mark Schoenebaum notes that the valuations of big biotech companies is trading below that of the S&P 500 for only the […]
“That’s a high-profile move. That could make people concerned,” said Steve Massocca of Wedbush Securities. “It’s not exactly the cheapest group around. It’s got an elevated valuation here. It does nothing but go up. It doesn’t take much to create a wobble.””It doesn’t appear to be hurting other speculative areas. The social media index is up three-quarters of a percent,” […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
Stock Market No Clear Direction As Investors React To Quarterly Earnings ReleasesStock-Markets / Stock Markets 2015Apr 23, 2015 – 04:47 PM GMTBy: Paul_RejczakBriefly: In our opinion, speculative short positions are favored (with stop-loss at 2,140, and profit target at 1,980, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook is bearish:Intraday outlook (next 24 hours): bearishShort-term outlook (next […]
Markets Care About Money PrintingWhile the Federal Reserve has ended its quantitative easing (QE) program, central banks in Europe and Asia continue to implement ultra-easy monetary policies, which provide a tailwind for foreign stock markets. China announced additional economic stimulus last Sunday and more may be on the way. From The Wall Street Journal:
China’s central bank has long been critical […]
The “Good Friday” Jobs Report may be one of the most anticlimactic in memory as the sharp slowdown in the jobs growth rate ran smack into a market closed for the holiday weekend and while it truly was a good Friday for anyone still long the PowerShares DB US Dollar Index Bullish Fund (UUP), what sort of situation will investors […]
Since reaching all-time highs on March 19, the three largest biotech exchange traded funds are off 4.4% with the SPDR S&P Biotech ETF (XBI) ranking as the worst offender of the trio with a loss of 5.7%.XBI’s recent struggles illustrate the ETF’s risk/reward proposition. As an equal-weight ETF, the $2.1 billion XBI is dependent on the largest biotech stocks, such […]
NEW YORK (MarketWatch)—Many market watchers warned Monday about biotech stocks, and the big beatdown came Wednesday.Should you buy biotech on the dip? Some market watchers suggest holding off.Within the largest biotech ETF, less than half of the stocks are trading above their 50-day average, down from more than 80% in the past week, said Sundial Capital Research in a note […]
